» Articles » PMID: 2289172

Regional Neuroprotective Effects of Pentobarbital on Ischemia-induced Brain Damage

Overview
Journal Brain Res Bull
Specialty Neurology
Date 1990 Dec 1
PMID 2289172
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the neuroprotective effect of pentobarbital, a GABAA receptor-effector, on ischemic neuronal damage in the gerbils. The animals were allowed to survive for 7 days after 10-min ischemia induced by bilateral occlusion of the common carotid arteries. Morphological changes and abnormal calcium accumulation were evaluated in selectively vulnerable areas after ischemia. Pentobarbital (40 mg/kg, IP), administered 30 min prior to ischemia, significantly reduced neuronal cell loss in the neocortex, the striatum, and the hippocampal CA3 sector. However, pentobarbital failed to prevent the damage to the hippocampal CA1 sector and the thalamus. 45Ca autoradiographic study also revealed that a marked calcium accumulation was found in the selectively vulnerable regions after ischemia, which was consistent with the extent of histological neuronal damage. The abnormal calcium accumulation was reduced in the sites corresponding to most of the regions in which the protective effect of pentobarbital was found. The results suggest that ischemia-induced neuronal damage may be partly caused by an imbalance between excitatory and inhibitory input.

Citing Articles

Ultrasound-sensitive nanodroplets achieve targeted neuromodulation.

Lea-Banks H, Meng Y, Wu S, Belhadjhamida R, Hamani C, Hynynen K J Control Release. 2021; 332:30-39.

PMID: 33600879 PMC: 8089063. DOI: 10.1016/j.jconrel.2021.02.010.


Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke.

Vesterinen H, Currie G, Carter S, Mee S, Watzlawick R, Egan K Syst Rev. 2013; 2:33.

PMID: 23687965 PMC: 3665471. DOI: 10.1186/2046-4053-2-33.


Long-term changes in gerbil brain neurotransmitter receptors following transient cerebral ischaemia.

Araki T, Kato H, Kogure K, Kanai Y Br J Pharmacol. 1992; 107(2):437-42.

PMID: 1330176 PMC: 1907888. DOI: 10.1111/j.1476-5381.1992.tb12764.x.